Boon Shing Tan

846 total citations
18 papers, 645 citations indexed

About

Boon Shing Tan is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Boon Shing Tan has authored 18 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Infectious Diseases. Recurrent topics in Boon Shing Tan's work include Epigenetics and DNA Methylation (3 papers), Viral gastroenteritis research and epidemiology (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Boon Shing Tan is often cited by papers focused on Epigenetics and DNA Methylation (3 papers), Viral gastroenteritis research and epidemiology (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Boon Shing Tan collaborates with scholars based in Malaysia, Taiwan and United Kingdom. Boon Shing Tan's co-authors include Chee‐Onn Leong, Kai Hung Tiong, Heng Lungh Choo, Felicia Fei‐Lei Chung, Ling‐Wei Hii, Tracey D. Bradshaw, Chun‐Wai Mai, Alan Soo Beng Khoo, Rozita Rosli and Ruey‐Hwa Chen and has published in prestigious journals such as Development, Cancer Research and Oncogene.

In The Last Decade

Boon Shing Tan

17 papers receiving 640 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boon Shing Tan Malaysia 12 421 186 181 81 51 18 645
Kai Hung Tiong Malaysia 12 405 1.0× 114 0.6× 169 0.9× 141 1.7× 51 1.0× 18 680
Moon‐Taek Park South Korea 14 449 1.1× 113 0.6× 155 0.9× 40 0.5× 67 1.3× 27 668
Namrata Rastogi India 14 379 0.9× 135 0.7× 148 0.8× 82 1.0× 68 1.3× 20 706
Hanlin Zeng China 8 347 0.8× 93 0.5× 190 1.0× 52 0.6× 43 0.8× 14 511
Amal Shervington United Kingdom 14 366 0.9× 112 0.6× 174 1.0× 36 0.4× 42 0.8× 34 611
Weiwei Shao China 15 424 1.0× 165 0.9× 112 0.6× 58 0.7× 79 1.5× 38 675
Ji-Hak Jeong South Korea 15 369 0.9× 182 1.0× 151 0.8× 38 0.5× 60 1.2× 24 684
Wanghai Zhang United States 11 387 0.9× 72 0.4× 249 1.4× 75 0.9× 67 1.3× 16 683

Countries citing papers authored by Boon Shing Tan

Since Specialization
Citations

This map shows the geographic impact of Boon Shing Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boon Shing Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boon Shing Tan more than expected).

Fields of papers citing papers by Boon Shing Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boon Shing Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boon Shing Tan. The network helps show where Boon Shing Tan may publish in the future.

Co-authorship network of co-authors of Boon Shing Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Boon Shing Tan. A scholar is included among the top collaborators of Boon Shing Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boon Shing Tan. Boon Shing Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wong, Siew Tung, et al.. (2025). Tupaia orthoreovirus: The first successful isolation of a novel Mammalian orthoreovirus from treeshrews in Malaysia. Journal of Virological Methods. 337. 115189–115189.
2.
Wong, Siew Tung, et al.. (2025). Safety profile of sikamat virus and its oncolytic potential in leukemic cells and cancer stem cells. Scientific Reports. 15(1). 13817–13817. 1 indexed citations
3.
Leong, Pooi Pooi, et al.. (2024). TB or not TB: emerging mycobacteriaceae detected in a human patient, tree shrews, and soil. Discover Medicine. 1(1). 1 indexed citations
4.
Tan, Boon Shing, et al.. (2020). WD40 protein Wuho controls germline homeostasis via TRIM-NHL tumor suppressor Mei-p26 in Drosophila. Development. 147(2). 12 indexed citations
5.
Hii, Ling‐Wei, et al.. (2019). Histone deacetylase (HDAC) inhibitors and doxorubicin combinations target both breast cancer stem cells and non-stem breast cancer cells simultaneously. Breast Cancer Research and Treatment. 179(3). 615–629. 29 indexed citations
6.
Tan, Boon Shing, Yu‐Chi Chou, Hsin‐Yi Chen, et al.. (2019). LncRNA NORAD is repressed by the YAP pathway and suppresses lung and breast cancer metastasis by sequestering S100P. Oncogene. 38(28). 5612–5626. 94 indexed citations
7.
Huang, Xin, et al.. (2019). Abstract P6-20-16: BAT8003, a potent anti-Trop-2 antibody-drug conjugate, for the treatment of triple negative breast cancer. Cancer Research. 79(4_Supplement). P6–20. 6 indexed citations
9.
Chung, Felicia Fei‐Lei, Vijay J. Raja, Boon Shing Tan, et al.. (2017). Jerantinine A induces tumor-specific cell death through modulation of splicing factor 3b subunit 1 (SF3B1). Scientific Reports. 7(1). 42504–42504. 47 indexed citations
10.
Tan, Boon Shing, et al.. (2017). Single-walled carbon nanotubes (SWCNTs) inhibit heat shock protein 90 (HSP90) signaling in human lung fibroblasts and keratinocytes. Toxicology and Applied Pharmacology. 329. 347–357. 13 indexed citations
11.
Tiong, Kai Hung, Boon Shing Tan, Heng Lungh Choo, et al.. (2016). Fibroblast growth factor receptor 4 (FGFR4) and fibroblast growth factor 19 (FGF19) autocrine enhance breast cancer cells survival. Oncotarget. 7(36). 57633–57650. 66 indexed citations
12.
Tan, Boon Shing, Kai Hung Tiong, Heng Lungh Choo, et al.. (2015). Mutant p53-R273H mediates cancer cell survival and anoikis resistance through AKT-dependent suppression of BCL2-modifying factor (BMF). Cell Death and Disease. 6(7). e1826–e1826. 89 indexed citations
13.
14.
Tan, Boon Shing, Chun‐Wai Mai, Kai Hung Tiong, et al.. (2013). 6-Shogaol inhibits breast and colon cancer cell proliferation through activation of peroxisomal proliferator activated receptor γ (PPARγ). Cancer Letters. 336(1). 127–139. 83 indexed citations
15.
Tan, Boon Shing, Kai Hung Tiong, Heng Lungh Choo, et al.. (2011). CYP2S1 and CYP2W1 Mediate 2-(3,4-Dimethoxyphenyl)-5-Fluorobenzothiazole (GW-610, NSC 721648) Sensitivity in Breast and Colorectal Cancer Cells. Molecular Cancer Therapeutics. 10(10). 1982–1992. 60 indexed citations
16.
Tan, Boon Shing, et al.. (2011). Suppression of BCL-2 synergizes cisplatin sensitivity in nasopharyngeal carcinoma cells. Cancer Letters. 314(2). 166–175. 36 indexed citations
17.
Leong, Chee‐Onn, et al.. (2011). Abstract C75: CYP2S1 and CYP2W1 mediate 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW610, NSC 721648) sensitivity in breast and colorectal cancer cells.. Molecular Cancer Therapeutics. 10(11_Supplement). C75–C75. 1 indexed citations
18.
Tiong, Kai Hung, et al.. (2010). Rapamycin synergizes cisplatin sensitivity in basal-like breast cancer cells through up-regulation of p73. Breast Cancer Research and Treatment. 128(2). 301–313. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026